Patients With Pretreated DME May Need More Frequent Aflibercept Injections

(MedPage Today) — Patients with prior treatment for diabetic macular edema (DME) may require more frequent dosing of aflibercept (Eylea), according to a subgroup analysis of the PHOTON trial presented at the recent Association for Research in…

Source link : https://www.medpagetoday.com/meetingcoverage/arvovideopearls/116039

Author :

Publish date : 2025-06-12 16:29:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Patients With Pretreated DME May Need More Frequent Aflibercept Injections

The Vera Rubin Observatory is about to completely transform astronomy

More Data Back CAR T-Cell Therapy for Lupus, With Promise of Wider Availability

Related Posts

Constipated children being failed by lack of services, say parents

Midlife Brain Power Drops as Artificial Sweetener Use Rises

More Advanced Prostate Cancers After USPSTF Guideline Change

Private Equity Acquisition of Opioid Programs No Help for Methadone Supply

HHS Employees Call for RFK Jr. to Resign

Why solar power is the only viable power source in the long run

Constipated children being failed by lack of services, say parents

Midlife Brain Power Drops as Artificial Sweetener Use Rises

More Advanced Prostate Cancers After USPSTF Guideline Change

Private Equity Acquisition of Opioid Programs No Help for Methadone Supply

HHS Employees Call for RFK Jr. to Resign

Why solar power is the only viable power source in the long run

Trump Admin Throws Up Hands, Pledges to Restore HHS Websites

Hospital Launches Misinformation Tracker

Categories

Archives